BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25227628)

  • 1. Statin use and risk of liver cancer: an update meta-analysis.
    Shi M; Zheng H; Nie B; Gong W; Cui X
    BMJ Open; 2014 Sep; 4(9):e005399. PubMed ID: 25227628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use and risk of pancreatic cancer: a meta-analysis.
    Cui X; Xie Y; Chen M; Li J; Liao X; Shen J; Shi M; Li W; Zheng H; Jiang B
    Cancer Causes Control; 2012 Jul; 23(7):1099-111. PubMed ID: 22562222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and risk of Parkinson's disease: A meta-analysis.
    Sheng Z; Jia X; Kang M
    Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and primary liver cancer: a meta-analysis of observational studies.
    Pradelli D; Soranna D; Scotti L; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
    Eur J Cancer Prev; 2013 May; 22(3):229-34. PubMed ID: 23010949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.
    de Vries FM; Denig P; Pouwels KB; Postma MJ; Hak E
    Drugs; 2012 Dec; 72(18):2365-73. PubMed ID: 23186103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis.
    Chang Y; Liu Q; Zhou Z; Ding Y; Yang M; Xu W; Chen K; Zhang Q; Wang Z; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820934881. PubMed ID: 32552476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis.
    Zhang X; Lou D; Fu R; Wu F; Zheng D; Ma X
    Curr Med Chem; 2024; 31(6):762-775. PubMed ID: 37393552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and risk of breast cancer: a meta-analysis of observational studies.
    Undela K; Srikanth V; Bansal D
    Breast Cancer Res Treat; 2012 Aug; 135(1):261-9. PubMed ID: 22806241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis.
    Kunutsor SK; Seidu S; Khunti K
    Lancet Haematol; 2017 Feb; 4(2):e83-e93. PubMed ID: 28089655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2006 Oct; 24(30):4808-17. PubMed ID: 17001070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
    JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use and risk of bladder cancer: a meta-analysis.
    Zhang XL; Geng J; Zhang XP; Peng B; Che JP; Yan Y; Wang GC; Xia SQ; Wu Y; Zheng JH
    Cancer Causes Control; 2013 Apr; 24(4):769-76. PubMed ID: 23361339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of studies using statins as a reducer for primary liver cancer risk.
    Zhong GC; Liu Y; Ye YY; Hao FB; Wang K; Gong JP
    Sci Rep; 2016 May; 6():26256. PubMed ID: 27198922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and cancer risk: a meta-analysis.
    Dale KM; Coleman CI; Henyan NN; Kluger J; White CM
    JAMA; 2006 Jan; 295(1):74-80. PubMed ID: 16391219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Statins on Relative Risk of Fractures for Older Adults: An Updated Systematic Review With Meta-Analysis.
    Shi R; Mei Z; Zhang Z; Zhu Z
    J Am Med Dir Assoc; 2019 Dec; 20(12):1566-1578.e3. PubMed ID: 31395495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and risk of prostate cancer: a meta-analysis of observational studies.
    Bansal D; Undela K; D'Cruz S; Schifano F
    PLoS One; 2012; 7(10):e46691. PubMed ID: 23049713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.
    Bonovas S; Filioussi K; Flordellis CS; Sitaras NM
    J Clin Oncol; 2007 Aug; 25(23):3462-8. PubMed ID: 17687150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin treatment in multiple sclerosis: a systematic review and meta-analysis.
    Pihl-Jensen G; Tsakiri A; Frederiksen JL
    CNS Drugs; 2015 Apr; 29(4):277-91. PubMed ID: 25795002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.